Google
×
May 29, 2024 · Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is inversely associated with colorectal cancer (CRC) risk. In meta-analyses and ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Sci Adv. 2024 May 31;10(22):eadk3121 ...
May 29, 2024 · Genetic variants on chromosomes 5 and 6 modulate protective associations between regular aspirin/NSAID use and colorectal cancer. Go to: ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Science advances. Authors. David Drew.
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Drew, David A. ;; Kim, Andre E. ;; Lin ...
Jun 11, 2024 · After adjusting for multiple comparisons, we identified statistically significant interactions between regular aspirin/NSAID use and variants in ...
Dive into the research topics of 'Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer'.
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Drew, David A; Kim, Andre E; Lin, Yi ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. David A Drew, Andre E Kim, Yi Lin ...
May 29, 2024 · Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Two genome-wide ...